Fruzaqla given in combination with sintilimab slowed progression in the second line for those with locally advanced or metastatic renal cell carcinoma.

The Cyber Cell of District Police Rajouri, by demonstrating its unwavering commitment to combating cyber crime, recovered ...

EKA Mobility partners with VDL Groep, KPIT Technologies, and BPCL to deploy a hydrogen fuel cell bus at Cochin International ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January ...

AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and ...

("Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx's PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer ...

Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite challenges like cost and access.

Chinese pair Hutchmed and Innovent Biologics have announced that the FRUSICA-2 Phase II/III trial of fruquintinib and ...

The battery manufacturer CustomCells is part of the ‘Innovation and Future Agenda’ of the German state of Baden-Württemberg.

Lotte Biologics announced on the 13th that it has signed a memorandum of understanding (MOU) for collaboration in the ...

MILAN, March 13, 2025 /PRNewswire/ -- CESI strengthens its leadership in the space energy sector with the inauguration of a new production line at its laboratories in Milan. At the same time ...